OBN is a networking organization which supports and brings together the UK’s innovative life sciences companies, corporate partners and investors at various events and functions during the year.
The OBN Awards 2017 (5th October in Oxford) celebrate innovation and achievement across the UK life sciences Industry.
The awards cover the following categories: Biotech, Medtech, Synthetic Biology, Digital Healthcare and Investment and recognize achievements from emerging to late stage R&D companies to large pharma and life sciences investors.
Last year, Mercia Technologies won the “Highest Impact Investor” award sponsored by Singer Capital Markets.
This year, Singer Capital Markets is proud to sponsor the “Outstanding Achievement” award.
To learn more about it, email firstname.lastname@example.org